We turn American Heart Association's Science News into an interactive format for you. Find something interesting or have a question? Let us know in the comments.

See the latest Science News from the American Heart Association at my.americanheart.org/sciencenews.

Latest Posts


Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention

  • Mortality from cardiovascular disease has declined in recent decades, but unhealthy behaviors such as unhealthy body weight, sedentary behaviors, and tobacco use remain prevalent in the U.S. population. The American Heart Association 2020 Strategic Impact Goals target health behaviors and health indicators.
  • Mobile technologies are a pervasive component of the modern American environment and mobile devices permit collection of data in real time – enabling researchers to assess multiple behaviors in various contexts and inform the development of interventions to prompt behavior change.
  • While many mobile health interventions do not currently have the evidence base to support their inclusion in clinical recommendations, they hold great promise for lifestyle interventions to promote better patient health.
    Read the full article in Circulation
Posted by Kelly Kozakowski on Aug 13, 2015 3:48 PM CDT

Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease

  • Major Depressive Disorder (MDD) and Bipolar Disorder (BD) affects about 10% of adolescents in the US.
  • The association between depression and CVD among adults is well known.
  • MDD and BD among youth satisfy the criteria for, and should be included in the list of, moderate risk conditions for cardiovascular disease along with chronic inflammatory disease, human immunodeficiency virus, and nephrotic syndrome.

    Read the full article in Circulation
Posted by Stacy AHA Science on Aug 10, 2015 3:25 PM CDT

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence

  • After reaching a peak in the 1960s, mortality rates from coronary artery disease (CAD) have declined steadily in the United States. While there has also been improvements in CAD mortality in people with type 2 diabetes mellitus, they are at incrementally higher cardiovascular risk than nondiabetics.
  • This scientific statement provides a focused update of recent studies on CVD risk factor control and prevention, and screening for renal and subclinical coronary artery disease in people with diabetes.
  • Several key research questions remain to make greater strides in lowering clinical cardiovascular disease in this high-risk patient population.

    Read the full article in Circulation
Posted by Kelly Kozakowski on Aug 5, 2015 1:12 PM CDT

Social Determinants of Risk and Outcomes for Cardiovascular Disease

  • The prevalence of CVD is expected to rise in the US by 10% between 2010 and 2030, and it is argued that this is not explained solely by an aging population.
  • This statement summarizes the current state of knowledge about social factors as they relate to health.
  • Future directions are discussed as it relates to research that may attenuate these factors.

    Read the full article in Circulation
Posted by Kelly Kozakowski on Aug 4, 2015 2:28 PM CDT

Transformative Impact of Proteomics on Cardiovascular Health and Disease

  • The American Heart Association (AHA) summarizes advances in proteomics over the past 20 years that have catalyzed the capacity to address the experimental, translational, and clinical implications as applied to cardiovascular health and disease.
  • The statement extends beyond the typical literature review and offers guidance on the use of next-generation proteomics for future scientific discovery in the basic research laboratory and clinical settings.
  • Key successes that have energized the field are delineated in this statement; opportunities for proteomics to drive basic science research, facilitate clinical translation, and established diagnostic and therapeutic healthcare algorithms are discussed.
  • Challenges that remain to be solved before proteomic technologies can be readily translated from scientific discoveries to meaningful advances in cardiovascular care are also addressed.

    Read the full article in Circulation
Posted by Kelly Kozakowski on Jul 20, 2015 4:30 PM CDT


2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment

  • This update to the 2013 AIS Guideline provides an update to the management is ischemic stroke for endovascular treatment.
  • The AHA/ASA recommends, in addition to IV rtPA, endovascular treatment with stent retrievers in persons with a large cerebral artery occlusion (M1).
  • Key recommendations are made regarding the use of IV rtPA, endovascular treatment with stent retrievers, imaging and systems of care.
Read the full article in Stroke
Posted by Kelly Kozakowski on Jul 20, 2015 1:34 PM CDT

Mark Creager, MD, president of the American Heart Association, interviews BCVS 2015 program co-chairs Anthony Rosenzweig, MD, Åsa Gustafsson, PhD, and David Lefer, PhD about the highlights of the science they have chosen for the meeting in New Orleans and its potential to improve patient care.

Posted by Alice Wolke on Jul 13, 2015 7:07 PM CDT
There is still time to register this weekend for the Basic Cardiovascular Sciences 2015 Scientific Sessions meeting that starts on Monday, July 13 in New Orleans, LA.


Develop new ideas and collaborations with your cardiovascular peers in this world-class city. BCVS 2015 offers state-of-the-art presentations on fascinating topics from invited speakers from all over the world.

Posted by Alice Wolke on Jul 10, 2015 2:32 PM CDT

Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness

  • Arterial stiffness is an important clinical measure that can independently predict CVD.
  • Research into arterial stiffness has increased, yet there is an absence of guidance for investigators.
  • Standardized research approaches will advance understanding of the complex role of arterial stiffness in age-related CVD risk.

    Read the full article in Circulation
Posted by Stacy AHA Science on Jul 9, 2015 3:44 PM CDT

The U.S. Food and Drug Administration today approved sacubitril/valsartan tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure.

FDA News Release new drug to treat heart failure

Posted by Stacy AHA Science on Jul 7, 2015 5:41 PM CDT
< Prev    1 2 3 4 5 6 7 8 9 ... 51   

Most Recent Comments

Sorry about that. The correct link is http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@sm...
Slide set link is not working
How does one access the slides for the 2015 EVT article?
My husband had a heart attack in hospital 2 days after colon surgery and the code team did not use defib machine or padd...
We have some interesting data coming in post pre-participation sports screening clinic. We performed the clinic l...

Login or Join

You must be logged in to comment on blogs.

Login using your My.AmericanHeart credentials:

Don't have an account?

Tag Cloud

Share With Colleagues

Share with colleagues: